StonvexLoading…
StonvexStonvexStonvexCore line items from CATX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $1.43M | $5.24M | $3.33M | $1.83M |
Operating Income | $-40.94M | $-29.27M | $-19.52M | $-9.76M |
Net Income | $-46.51M | $-21.83M | $-11.11M | $-371.00K |
EPS (Diluted) | $-1.74 | $-0.83 | $-0.45 | $0.00 |
Total Assets | $97.89M | $110.52M | $120.14M | $127.64M |
Total Liabilities | $22.71M | $11.75M | $11.49M | $9.62M |
Cash & Equivalents | $9.24M | $17.98M | $28.32M | $36.45M |
Free Cash Flow OCF − CapEx | $-37.98M | $-28.89M | $-18.55M | $-9.92M |
Shares Outstanding | 28.18M | 280.57M | 280.48M | 278.66M |